Do fluoxetine and buspirone cause hyperhidrosis (excessive sweating)?

Does Fluoxetine and Buspirone Cause Sweating?

Yes, fluoxetine commonly causes excessive sweating (hyperhidrosis), while buspirone causes sweating much less frequently—occurring in only about 1% of patients.

Fluoxetine and Sweating

Fluoxetine is well-established as a cause of hyperhidrosis. In controlled trials, excessive sweating was identified as a predominant adverse effect of fluoxetine treatment 1. This finding has been consistently replicated across multiple studies examining SSRIs.

A comprehensive meta-analysis of second-generation antidepressants demonstrated that SSRIs as a class significantly increase the risk of hyperhidrosis compared to placebo (RR = 2.93,95% CI: 2.46-3.47) 2. Fluoxetine specifically showed efficacy in reducing hyperhidrosis symptoms in social anxiety disorder patients, but this was because it treated the underlying anxiety—the medication itself is a known cause of sweating 3.

The mechanism appears related to serotonergic effects on thermoregulation and sympathetic nervous system activity. Interestingly, the meta-analysis found that increased dopamine transporter affinity of SSRI medications was associated with higher risk of hyperhidrosis 2.

Buspirone and Sweating

Buspirone causes sweating/clamminess in approximately 1% of patients, which is only marginally higher than placebo 4. According to FDA labeling data from controlled clinical trials, sweating/clamminess occurred in 1% of buspirone-treated patients versus less than 1% in placebo patients 4.

However, there is an important caveat: buspirone can cause diaphoresis (sweating) as part of serotonin syndrome when combined with other serotonergic agents 4. The FDA label specifically warns about serotonin syndrome symptoms including "diaphoresis" when buspirone is used with MAOIs, SSRIs, or other serotonergic drugs 4. This is a serious, potentially life-threatening condition requiring immediate discontinuation.

Clinical Implications

For Fluoxetine-Related Sweating:

• Expect this side effect in a substantial proportion of patients
• Management options include:
  1. Dose reduction (first-line approach)
  2. Switching to bupropion or vortioxetine (these have lower sweating risk) 2
  3. Adding benztropine or cyproheptadine if the antidepressant must be continued 5
  4. Discontinuation if symptoms are intolerable and alternatives exist 5

For Buspirone-Related Sweating:

• Sweating is uncommon with buspirone monotherapy (1% incidence)
• Primary concern is serotonin syndrome when combined with other serotonergic drugs
• Monitor for sweating accompanied by mental status changes, autonomic instability, or neuromuscular symptoms—these require immediate intervention 4

Critical Pitfall to Avoid:

Do not combine buspirone with SSRIs like fluoxetine without careful monitoring for serotonin syndrome, as this combination increases the risk of diaphoresis as part of a potentially dangerous syndrome rather than as an isolated side effect 4.

The American College of Physicians recommends selecting antidepressants based on adverse effect profiles 6, and excessive sweating should be discussed with patients before initiating fluoxetine, as it represents a common and potentially distressing side effect that may impact medication adherence.